Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Satiety responsiveness but not food reward is modified in response to an acute bout of low versus high intensity exercise in healthy adults.

Thivel D, Fillon A, Genin PM, Miguet M, Khammassi M, Pereira B, Boirie Y, Duclos M, Drapeau V, Blundell JE, Tremblay A, Finlayson G, Mathieu ME, Metz L.

Appetite. 2019 Oct 23;145:104500. doi: 10.1016/j.appet.2019.104500. [Epub ahead of print]

PMID:
31655090
2.

Promoting Physical Activity and Reducing Sedentary Time Among Tertiary Workers: Position Stand From the French National ONAPS.

Genin PM, Dutheil F, Larras B, Esquirol Y, Boirie Y, Tremblay A, Pereira B, Praznoczy C, Thivel D, Duclos M.

J Phys Act Health. 2019 Jul 30:1-2. doi: 10.1123/jpah.2019-0154. [Epub ahead of print] No abstract available.

PMID:
31365902
3.

Is workplace an appropriate setting for the promotion of physical activity? A new framework for worksite interventions among employees.

Genin P, Beaujouan J, Thivel D, Duclos M.

Work. 2019;62(3):421-426. doi: 10.3233/WOR-192873.

PMID:
30856142
4.

Results from France's 2018 Report Card on Physical Activity for Children and Youth.

Aubert S, Aucouturier J, Ganière C, Fillon A, Genin P, Schipman J, Larras B, Praznoczy C, Duclos M, Thivel D.

J Phys Act Health. 2018 Nov 1;15(S2):S360-S362. doi: 10.1123/jpah.2018-0511. No abstract available.

PMID:
30475139
5.

Physical Activity, Inactivity, and Sedentary Behaviors: Definitions and Implications in Occupational Health.

Thivel D, Tremblay A, Genin PM, Panahi S, Rivière D, Duclos M.

Front Public Health. 2018 Oct 5;6:288. doi: 10.3389/fpubh.2018.00288. eCollection 2018. Review.

6.

Effect of Work-Related Sedentary Time on Overall Health Profile in Active vs. Inactive Office Workers.

Genin PM, Dessenne P, Finaud J, Pereira B, Dutheil F, Thivel D, Duclos M.

Front Public Health. 2018 Oct 1;6:279. doi: 10.3389/fpubh.2018.00279. eCollection 2018.

7.

Employees' adherence to worksite physical activity programs: Profiles of compliers versus non-compliers.

Genin PM, Pereira B, Thivel D, Duclos M.

Work. 2018;60(3):507-510. doi: 10.3233/WOR-182745.

PMID:
30040776
8.

Health and Fitness Benefits But Low Adherence Rate: Effect of a 10-Month Onsite Physical Activity Program Among Tertiary Employees.

Genin PM, Dessenne P, Finaud J, Pereira B, Thivel D, Duclos M.

J Occup Environ Med. 2018 Sep;60(9):e455-e462. doi: 10.1097/JOM.0000000000001394.

PMID:
30020214
9.

Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer.

Weil R, Laplantine E, Curic S, Génin P.

Front Immunol. 2018 Jun 19;9:1243. doi: 10.3389/fimmu.2018.01243. eCollection 2018. Review.

10.

Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.

Monel B, Compton AA, Bruel T, Amraoui S, Burlaud-Gaillard J, Roy N, Guivel-Benhassine F, Porrot F, Génin P, Meertens L, Sinigaglia L, Jouvenet N, Weil R, Casartelli N, Demangel C, Simon-Lorière E, Moris A, Roingeard P, Amara A, Schwartz O.

EMBO J. 2017 Jun 14;36(12):1653-1668. doi: 10.15252/embj.201695597. Epub 2017 May 4.

11.

Effect of a 5-Month Worksite Physical Activity Program on Tertiary Employees Overall Health and Fitness.

Genin PM, Degoutte F, Finaud J, Pereira B, Thivel D, Duclos M.

J Occup Environ Med. 2017 Feb;59(2):e3-e10. doi: 10.1097/JOM.0000000000000945.

PMID:
28166129
12.

Reproducibility of an in-laboratory test meal to assess ad libitum energy intake in adolescents with obesity.

Thivel D, Genin PM, Mathieu ME, Pereira B, Metz L.

Appetite. 2016 Oct 1;105:129-33. doi: 10.1016/j.appet.2016.05.028. Epub 2016 May 22.

PMID:
27224220
13.

Regulation of TBK1 activity by Optineurin contributes to cell cycle-dependent expression of the interferon pathway.

Weil R, Laplantine E, Génin P.

Cytokine Growth Factor Rev. 2016 Jun;29:23-33. doi: 10.1016/j.cytogfr.2016.03.001. Epub 2016 Mar 4. Review.

PMID:
26976762
14.

Reduced neural response to food cues following exercise is accompanied by decreased energy intake in obese adolescents.

Fearnbach SN, Silvert L, Keller KL, Genin PM, Morio B, Pereira B, Duclos M, Boirie Y, Thivel D.

Int J Obes (Lond). 2016 Jan;40(1):77-83. doi: 10.1038/ijo.2015.215. Epub 2015 Oct 9.

PMID:
26449418
15.

Correction: Optineurin Regulates the Interferon Response in a Cell Cycle-Dependent Manner.

Génin P, Cuvelier F, Lambin S, Côrte-Real Filipe J, Autrusseau E, Laurent C, Laplantine E, Weil R.

PLoS Pathog. 2015 Jun 11;11(6):e1004971. doi: 10.1371/journal.ppat.1004971. eCollection 2015 Jun. No abstract available.

16.

Optineurin regulates the interferon response in a cell cycle-dependent manner.

Génin P, Cuvelier F, Lambin S, Côrte-Real Filipe J, Autrusseau E, Laurent C, Laplantine E, Weil R.

PLoS Pathog. 2015 Apr 29;11(4):e1004877. doi: 10.1371/journal.ppat.1004877. eCollection 2015 Apr. Erratum in: PLoS Pathog. 2015 Jun;11(6):e1004971.

17.

Lean adolescents achieve higher intensities but not higher energy expenditure while playing active video games compared with obese ones.

Chaput JP, Genin PM, Le Moel B, Pereira B, Boirie Y, Duclos M, Thivel D.

Pediatr Obes. 2016 Apr;11(2):102-6. doi: 10.1111/ijpo.12027. Epub 2015 Apr 8.

PMID:
25855028
18.

[Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France].

MacGrogan G, Mathieu MC, Poulet B, Penault-Llorca F, Vincent-Salomon A, Roger P, Treilleux I, Valent A, Antoine M, Becette V, Bor C, Brabencova E, Charafe-Jauffret E, Chenard MP, Dauplat MM, Delrée P, Devouassoux M, Fiche M, Fondrevelle ME, Fridman V, Garbar C, Genin P, Ghnassia JP, Haudebourg J, Laberge-Le Couteulx S, Loussouarn D, Maran-Gonzalez A, Marcy M, Michenet P, Sagan C, Trassard M, Verriele V, Arnould L, Lacroix-Triki M; GEFPICS.

Ann Pathol. 2014 Oct;34(5):366-72. doi: 10.1016/j.annpat.2014.08.017. Epub 2014 Sep 26. French.

PMID:
25439989
19.

[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].

Penault-Llorca F, Vincent-Salomon A, MacGrogan G, Roger P, Treilleux I, Valent A, Mathieu MC, Antoine M, Becette V, Bor C, Brabencova E, Charafe-Jauffret E, Chenard MP, Dauplat MM, Delrée P, Devouassoux M, Fiche M, Fondrevelle ME, Fridman V, Garbar C, Genin P, Ghnassia JP, Haudebourg J, Laberge-Le Couteulx S, Loussouarn D, Maran-Gonzalez A, Marcy M, Michenet P, Poulet B, Sagan C, Trassard M, Verriele V, Arnould L, Lacroix-Triki M; GEFPICS.

Ann Pathol. 2014 Oct;34(5):352-65. doi: 10.1016/j.annpat.2014.08.018. Epub 2014 Sep 26. French.

PMID:
25439988
20.

Breast microcalcifications: the lesions in anatomical pathology.

Henrot P, Leroux A, Barlier C, Génin P.

Diagn Interv Imaging. 2014 Feb;95(2):141-52. doi: 10.1016/j.diii.2013.12.011. Epub 2014 Feb 10.

21.

Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.

Chretien AS, Harlé A, Meyer-Lefebvre M, Rouyer M, Husson M, Ramacci C, Harter V, Genin P, Leroux A, Merlin JL.

Cancer Med. 2013 Feb;2(1):11-20. doi: 10.1002/cam4.47. Epub 2013 Feb 3.

22.

Using one-step nucleic acid amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients avoids second surgery and accelerates initiation of adjuvant therapy.

Klingler S, Marchal F, Rauch P, Kenouchi O, Chrétien AS, Genin P, Leroux A, Merlin JL.

Ann Oncol. 2013 Sep;24(9):2305-9. doi: 10.1093/annonc/mdt160. Epub 2013 May 9.

PMID:
23661291
23.

Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.

Harlé A, Busser B, Rouyer M, Harter V, Genin P, Leroux A, Merlin JL.

Virchows Arch. 2013 Mar;462(3):329-35. doi: 10.1007/s00428-013-1380-x. Epub 2013 Feb 12.

PMID:
23400679
24.

Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.

Harlé A, Lion M, Lozano N, Husson M, Harter V, Genin P, Merlin JL.

Oncol Rep. 2013 Mar;29(3):1043-52. doi: 10.3892/or.2013.2229. Epub 2013 Jan 8.

PMID:
23314198
25.

Toward an integrative view of Optineurin functions.

Kachaner D, Génin P, Laplantine E, Weil R.

Cell Cycle. 2012 Aug 1;11(15):2808-18. doi: 10.4161/cc.20946. Epub 2012 Aug 1. Review.

PMID:
22801549
26.

Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression.

Génin P, Lin R, Hiscott J, Civas A.

PLoS One. 2012;7(6):e38336. doi: 10.1371/journal.pone.0038336. Epub 2012 Jun 7.

27.

Optineurin: a new vision of cell division control.

Kachaner D, Laplantine E, Génin P, Weil R.

Cell Cycle. 2012 Apr 15;11(8):1481-2. doi: 10.4161/cc.20116. Epub 2012 Apr 15. No abstract available.

PMID:
22487679
28.

Sentinel lymph node biopsy in patients with conjunctival and eyelid cancers: experience in 17 patients.

Maalouf TJ, Dolivet G, Angioi KS, Leroux A, Genin P, George JL.

Ophthalmic Plast Reconstr Surg. 2012 Jan-Feb;28(1):30-4. doi: 10.1097/IOP.0b013e31822fb44b.

PMID:
22262287
29.

[Metaplastic carcinomas of the breast: a morphological and immunohistochemical study].

Gauchotte G, Gauchotte E, Bressenot A, Verhaeghe JL, Guillemin F, Leroux A, Genin P.

Ann Pathol. 2011 Feb;31(1):18-27. doi: 10.1016/j.annpat.2010.10.007. Epub 2011 Jan 26. French.

PMID:
21349384
30.

[Update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].

Penault-Llorca F, Vincent-Salomon A, Bellocq JP, Matthieu MC, Grogan GM, Treilleux I, Ettore F, Laberge-Le Couteulx S, Sigal B, Couturier J, Lacroix-Triki M, Antoine M, Balaton A, Baranzelli MC, Becette V, Blanc-Fournier C, Bibeau F, Brabencova E, Croce S, Fridman V, Génin P, Ghnassia JP, Jacquemier J, Poulet B, Roger P, Sagan C, Tas P, Trassard M, Verriele V, Arnould L; GEFPICS.

Ann Pathol. 2010 Oct;30(5):357-73. doi: 10.1016/j.annpat.2010.07.001. Epub 2010 Oct 16. French.

PMID:
21055523
31.

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Génin P, Civas A, Ryffel B, Kanellopoulos J, Tschopp J, André F, Lidereau R, McLaughlin NM, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L.

Nat Med. 2009 Oct;15(10):1170-8. doi: 10.1038/nm.2028. Epub 2009 Sep 20.

PMID:
19767732
32.

The role of differential expression of human interferon--a genes in antiviral immunity.

Génin P, Vaccaro A, Civas A.

Cytokine Growth Factor Rev. 2009 Aug;20(4):283-95. doi: 10.1016/j.cytogfr.2009.07.005. Epub 2009 Aug 3. Review.

PMID:
19651532
33.

RIG-I-like receptors: sensing and responding to RNA virus infection.

Nakhaei P, Genin P, Civas A, Hiscott J.

Semin Immunol. 2009 Aug;21(4):215-22. doi: 10.1016/j.smim.2009.05.001. Epub 2009 Jun 17. Review.

PMID:
19539500
34.

Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer.

Chergui F, Chrétien AS, Bouali S, Ramacci C, Rouyer M, Bastogne T, Genin P, Leroux A, Merlin JL.

Clin Chem. 2009 Jul;55(7):1327-36. doi: 10.1373/clinchem.2008.116632. Epub 2009 May 14.

35.

Differential regulation of human interferon A gene expression by interferon regulatory factors 3 and 7.

Génin P, Lin R, Hiscott J, Civas A.

Mol Cell Biol. 2009 Jun;29(12):3435-50. doi: 10.1128/MCB.01805-08. Epub 2009 Apr 6.

36.

Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages.

Solis M, Goubau D, Romieu-Mourez R, Genin P, Civas A, Hiscott J.

Biochem Pharmacol. 2006 Nov 30;72(11):1469-76. Epub 2006 Jul 17. Review.

PMID:
16846591
37.

Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.

Civas A, Génin P, Morin P, Lin R, Hiscott J.

J Biol Chem. 2006 Feb 24;281(8):4856-66. Epub 2005 Dec 27.

38.

Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases.

Caly M, Genin P, Ghuzlan A A, Elie C, Fréneaux P, Klijanienko J, Rosty C, Sigal-Zafrani B, Vincent-Salomon A, Douggaz A, Zidane M, Sastre-Garau X.

Anticancer Res. 2004 Sep-Oct;24(5B):3283-8.

39.

Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast.

Sastre-Garau X, Genin P, Rousseau A, Al Ghuzlan A, Nicolas A, Fréneaux P, Rosty C, Sigal-Zafrani B, Couturier J, Thiery JP, Magdelénat H, Vincent-Salomon A.

Histopathology. 2004 Aug;45(2):142-7.

PMID:
15279632
40.

[Histological margin and residual disease assessment for breast carcinoma].

Sigal-Zafrani B, Fourquet A, Vincent-Salomon A, Fréneaux P, Génin P, Rosty C, Sastre-Garau X.

Cancer Radiother. 2003 Nov;7 Suppl 1:120s-123s. Review. French.

PMID:
15124553
41.

Quality of follow-up of women with high grade squamous intra-epithelial lesion (HGSIL) cervical smears: results from a population-based organised screening programme.

Monnet E, Marquant A, Genin P, Mauny F, Carbillet JP.

Eur J Obstet Gynecol Reprod Biol. 2004 Apr 15;113(2):234-9.

PMID:
15063967
42.

Positive and negative control of virus-induced interferon-A gene expression.

Mesplède T, Navarro S, Génin P, Morin P, Island ML, Bonnefoy E, Civas A.

Autoimmunity. 2003 Dec;36(8):447-55. Review.

PMID:
14984021
43.

Wide metastatic spreading in infiltrating lobular carcinoma of the breast.

Ferlicot S, Vincent-Salomon A, Médioni J, Genin P, Rosty C, Sigal-Zafrani B, Fréneaux P, Jouve M, Thiery JP, Sastre-Garau X.

Eur J Cancer. 2004 Feb;40(3):336-41.

PMID:
14746850
44.

Overexpression/amplification of HER-2/neu is uncommon in invasive carcinoma of the uterine cervix.

Rosty C, Couturier J, Vincent-Salomon A, Genin P, Fréneaux P, Sigal-Zafrani B, Sastre-Garau X.

Int J Gynecol Pathol. 2004 Jan;23(1):13-7.

PMID:
14668544
45.
46.

Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers.

Cazals-Hatem D, Vilgrain V, Genin P, Denninger MH, Durand F, Belghiti J, Valla D, Degott C.

Hepatology. 2003 Mar;37(3):510-9.

PMID:
12601347
47.

Regulation of virus-induced interferon-A genes.

Civas A, Island ML, Génin P, Morin P, Navarro S.

Biochimie. 2002 Jul;84(7):643-54. Review.

PMID:
12453636
48.

Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells.

Sharma S, Grandvaux N, Mamane Y, Genin P, Azimi N, Waldmann T, Hiscott J.

J Immunol. 2002 Sep 15;169(6):3120-30.

49.

[Undifferentiated embryonal sarcoma of the liver in an adult: a case report].

Diedhiou A, Genin P, Terris B, Sauvanet A, Belghiti J, Degott C.

Ann Pathol. 2002 Apr;22(2):134-6. French.

PMID:
12124497
50.

Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice.

Fréneaux P, Nos C, Vincent-Salomon A, Genin P, Sigal-Zafrani B, Al Ghuzlan A, Birolini MJ, Clough K, Sastre-Garau X.

Mod Pathol. 2002 Jun;15(6):641-6.

Supplemental Content

Support Center